Clinical trials: MSA-C

Multiple System Atrophy (MSA)

Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)

• No Longer Available
• Age: All ages
• Expanded access

The purpose of this expanded access program is to provide access to the investigational drug verdiperstat in patients with Multiple System Atrophy (MSA).

Trial name

NCT05086094

Testing

BHV3241, verdiperstat

Where

United States

Sponsor

Biohaven Pharmaceuticals, Inc.